The Canadian Institutes of Health Research have started accepting research proposals for a clinical trial on chronic cerebrospinal venous insufficiency (CCSVI) and the research team will be made public in March 2012, according to the MS Society of Canada.
Darrel Gregory from the Alberta and Northwest Territories division of the MS Society said:
“What it involves is, forming angioplasty, inserting a balloon in the jugular veins to help the blood flow if it’s constricted.”
“It’s pretty simple in that respect, which doesn’t mean that there aren’t complications. There can be complications whenever you’re working with veins.”
Many Canadians suffering with MS have gone overseas to have CCSVI treatment.
“It’s not available in Canada yet, which is really unfortunate. We’re hoping that the clinical trials will help us determine that yes, it’s safe and yes, it works. So that we can have it available for people here.”
The government can now track how these overseas treatments are working for Canadians with MS as part of the MS monitoring system.
“What the government is doing is trying to gather data from people who had the procedure done, we had all these people go overseas or go to the United States to get the procedure done,” said Gregory. “Initially we weren’t monitoring them to see, basically, ‘How have you felt? Is it helping you or not helping you?’ The national monitoring system is simply a process to try and gather that data to determine who it’s working for, who it’s not working for and help us understand what the difference is. Why it’s working with some people and not with others. Try and understand it better.”
Federal Health Minister Leona Aglukkaq announced the trials the annual Canada health ministers’ meeting, saying that the government would budget between $3 and $5 million for the trials.
Vegreville-Wainwright MP Leon Benoit also talked about CCSVI research and the MS monitoring system in a private member’s motion.
“This is a very important issue to constituents in my riding as well as those who suffer from multiple sclerosis across the country,” said Benoit.
“I will continue to work with those from my riding and to be a voice in Ottawa to ensure that the wants and needs of MS sufferers and their families are heard. I look forward to the second hour of debate on M-274 in the new year.”
Angeles hospital in Mexico has been providing Canadian MS patients with high quality CCSVI treatment that is excellent value for money. To learn more about our protocols and successes please contact us using the form on the right.